A study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania ...

CIDRAP: Early-Life Infection Burden Continues Throughout Childhood, New Data Reveal New data from researchers in Denmark suggest that children who have a lot of common infections early in life ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

In a new study published in Lupus Science & Medicine, researchers reviewed randomized clinical trials (RCTs) to assess ...

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...

Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...

Trial underscores IROS's commitment to developing innovative therapies for unmet medical needs <li /> The study's success ...

An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...

An estimated 610,000 people in the US died from cancer last year. That’s almost the same amount of people who perished in the country’s four-year civil war. At least two million more people were ...

Imagine having a digital carbon copy of yourself that physicians could use to predict long-term risks for disease, assess how your body may respond to treatment, and simulate surgeries in advance. A ...

The global artificial intelligence in clinical trials market , valued at US$1.20 billion in 2023, is forecasted to grow at a ...